InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,303.27
(
0.12%
)
US TECH 100
18,066.00
(
-0.07%
)
Dow Jones
40,003.59
(
0.34%
)
Brent Oil
83.76
(
0.00%
)
Bitcoin
67,046.84
(
-0.05%
)
Post# of 648882
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

zee1

Send PM Follow Ignore
Followers 0
Posts 469
Boards Moderated 0
Alias Born 09/28/2006

zee1

Re: None

Friday, 06/27/2008 1:24:32 PM

Friday, June 27, 2008 1:24:32 PM

Post# of 648882
ARNA $ 5.68 +0.55 (+10.72%) 1,405,666 ARENA PHARMACEUTICALS INC COM ARNA: NASDAQ Healthcare : Biotechnology & Drugs



Lorcaserin hydrochloride, our most advanced drug candidate, is a promising investigative oral treatment for obesity. In September 2006, we initiated a Phase 3 clinical trial program to evaluate the safety and efficacy of lorcaserin for the treatment of obesity


http://www.arenapharm.com/wt/page/lho.html

drug pipeline
http://www.arenapharm.com/wt/page/prod_pipeline.html


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up